Martin Kulldorff, appointed by RFK Jr. to a federal vaccine panel, previously earned $33K as an expert witness in lawsuits targeting Merck's Gardasil vaccine.

Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s preventative antibody shot received authorization from the U.S. Food and Drug Administration (FDA).

Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs and vaccines. The company ...

In other recent news, Merck & Co. Inc. has reported successful Phase 3 trial results for its cholesterol drug, enlicitide decanoate, which showed significant reductions in LDL cholesterol levels. The ...

RAHWAY, N.J. - Merck & Co., Inc. (NYSE: MRK) today shared positive results from two Phase 3 clinical trials for enlicitide, an investigational oral cholesterol-lowering medication. The trials, named ...

Find the latest Merck & Co Inc (MRK | US58933Y1055) company operating performance and valuation plus latest price, trades, performance, company information and news. Merck & Co Inc (MRK) Industry Drug ...

India Business News: Dr. Reddy's Laboratories and Alvotech have partnered to co-develop, manufacture, and commercialize a biosimilar of Keytruda (pembrolizumab), a signifi ...

Dr. Reddy’s, Alvotech to co-develop, market biosimilar of Merck’s cancer drug Keytruda Worldwide sales of Keytruda in 2024 were $29.5 billion Updated - June 05, 2025 02:46 pm IST - HYDERABAD ...

Alvotech (ALVO) and Dr. Reddy’s Laboratories (RDY) have entered into a collaboration and license agreement to co-develop, manufacture, and commercialize a biosimilar candidate to Keytruda ...